The effect of subinhibitory concentrations of roxithromycin on the adhesion of three strains of Klebsiella pneumoniae to Int-407 cells was studied. Adherence was markedly inhibited and the effect was increased when roxithromycin was added to the cell culture medium rather than to the bacterial growth medium. Several assays were performed in order to understand the mechanism by which roxithromycin exerted this inhibitory effect. The greatest effect was obtained when roxithromycin was concentrated in the extracellular compartment; when roxithromycin was concentrated in the intracellular compartment, the inhibitory effect was reduced. The analysis of adhesion factors of bacteria showed that exposure to roxithromycin did not alter their apparent structure or quantity. Roxithromycin appears to interfere in the interaction between bacteria and eukaryotic receptors.
Introduction
Klebsiella pneumoniae accounts for 10% of nosocomial infections caused by Enterobacteriaceae in intensive care units, notably septicaemia, urinary and respiratory tract infections and meningitis. 1 Epidemiological studies have shown that infection is preceded by intestinal colonization. 2 Moreover, translocation through the intestinal mucosa has been demonstrated in mice. 3 Mucosal colonization by bacteria is always linked to adhesion processes. 4 The adhesion of K. pneumoniae to intestinal mucous membranes is a necessary stage in the establishment of nosocomial infections in vivo. It is possible to mimic in-vivo interactions of bacteria and mucous membranes by means of cultures of intestinal tissue cells in vitro. Indeed, strains of K. pneumoniae involved in nosocomial infections adhere in vitro to Caco-2 and Int-407 cells. 5, 6 Two adherence patterns have been observed: a diffuse pattern in which bacteria are scattered on the intestinal cell surface, and an aggregative adherence pattern where bacteria are piled up on the surface of the cells. Ninety percent of clinical isolates adhere in an aggregative pattern. 7 Roxithromycin is a macrolide antibiotic with a broad spectrum of antibacterial activity, but excluding many Gram-negative bacilli. We previously examined the effect of subinhibitory concentrations of roxithromycin on the adhesion of K. pneumoniae strains to Caco-2 cells. 8 Adhesion of K. pneumoniae strain CF504, which harbours the adhesin CF29K, to Caco-2 cells was diminished by Ͼ50% at concentrations of roxithromycin ranging from MIC/2 to MIC/8. Inhibition of adhesion was more effective when roxithromycin was added to the culture medium of the Caco-2 cells than when it was added to the growth medium of the bacteria. Further work with Int-407 cells has shown that addition of roxithromycin to the bacterial culture medium of K. pneumoniae strains CF504 and LM21 inhibits adherence of bacteria by Ͼ50% for a concentration of MIC/2 (32 mg/L). Roxithromycin added to the cell culture medium of the Int-407 cells inhibited adhesion of K. pneumoniae CF504 by 80% at a concentration of MIC/2 and by 46.5% at a concentration of MIC/8, and by 96.7% at MIC/2 and 42% at MIC/8 with strain LM21. 9 The present study was designed to extend this work and examine the effect of subinhibitory concentrations of roxithromycin on K. pneumoniae strain 3051, and to examine the mechanism by which roxithromycin exerts its inhibitory effect. infections. Strain CF504 presents a diffuse pattern of adherence; the protein, adhesin CF29K, is involved in adherence. 5 Strain LM21 adheres with an aggregative pattern, and a capsule-like material seems to be involved in this adhesion phenotype. 6 Strain 3051 adheres in a diffuse manner; the type 1 fimbriae are responsible for this adhesion. 7 Transconjugant Escherichia coli strain CF604 carries a 185 kb plasmid from K. pneumoniae CF504 and overexpresses the adhesin CF29K. 5 The MIC of roxithromycin (Roussel-Uclaf, Paris, France) was 64 mg/L for these four strains as determined by dilution on MuellerHinton broth and agar.
Materials and methods

Bacterial strains
Cell cultures
The cell line Int-407 (ATCC CCL6), derived from human embryonic jejunum and ileum, was used. The cells were cultured in Eagle's minimum essential medium (EMEM; Polylabo, Strasbourg, France), supplemented with 10% heat-inactivated fetal calf serum (Polylabo), 1% L-glutamine (Boehringer-Mannheim, Meylan, France), 1% nonessential amino acids (Boehringer-Mannheim), penicillin 10,000 U/mL, streptomycin 10 g/mL, and amphotericin B (ATGC Biotechnologie, Noisy Le Grand, France) 25 g/mL in an atmosphere of 5% carbon dioxide.
For adhesion assays, cells were cultured in 24-well tissue culture plates (ATGC Biotechnologie) to confluency.
Adhesion assays
All bacterial strains, except K. pneumoniae 3051, were suspended in EMEM containing 2% D-mannose (SigmaAldrich, L'Isle d' Abeau, France). Because of the mannose-sensitivity of the adhesion mediated by the type 1 fimbriae of K. pneumoniae 3051, 10 this strain was suspended in EMEM without D-mannose. Following suspension, 1 ϫ 10 8 bacteria were added to confluent monolayers of Int-407 cells and incubated for 3 h at 37°C in a 5% carbon dioxide atmosphere. After incubation, each well was rinsed three times in phosphate-buffered saline (PBS) pH 7.4 (Boehringer-Mannheim, Strasbourg, France) to remove the non-adherent bacteria. A solution of 0.5% Triton X-100 was then added to each well to release cells. Adherent bacteria were quantified by plating appropriate dilutions on Luria-Bertani (Difco, Paris, France) agar medium. Adherence was expressed in cfu/cm 2 of tissue culture well.
The inhibitory effect of roxithromycin
The effect of subinhibitory concentrations of roxithromycin was studied by adding roxithromycin at the dilution required to obtain the concentrations MIC/2 to MIC/32 in 1 mL of the culture medium of the Int-407 cells. The test strains of bacteria were suspended in cell culture medium containing the subinhibitory concentrations of roxithromycin and added to the Int-407 cells. Adhesion assays were performed as described above.
Effect on adhesion of exposure to roxithromycin before and after adhesion Effect of high intracellular concentration of roxithromycin.
Roxithromycin was concentrated within Int-407 cells using sodium bicarbonate (2.2 g/L in Mueller-Hinton medium) or pre-incubation for 1 h before adding bacteria. Appropriate dilutions of roxithromycin were added in order to obtain MIC/2 to MIC/32 in 1 mL of the cell culture medium. We have demonstrated previously that the MIC of roxithromycin was not changed in the presence of bicarbonates (unpublished data).
Effect of roxithromycin on adhering bacteria. After an adhesion step of 2 h, the supernatant was removed from each well. EMEM containing roxithromycin (MIC/4 and MIC/8) was added to the wells for 1 h. A control assay was performed with EMEM without roxithromycin.
Effect of roxithromycin on adhesin CF29K or on the capsule of K. pneumoniae LM21
Adhesin CF29K is overexpressed in E. coli strain CF604. E. coli CF604 were grown on Mueller-Hinton agar, then suspended in EMEM containing subinhibitory concentrations of roxithromycin (MIC/2 and MIC/4). Controls were carried out in parallel without antibiotic. Suspensions were incubated for 3 h at 37°C, after which the bacteria were harvested by centrifugation (15,000g, 4°C) and the surface proteins extracted as described below. Similarly, K. pneumoniae LM21 was grown overnight on Mueller-Hinton agar plates, suspended in EMEM containing roxithromycin (MIC/2, MIC/4 and MIC/8) and incubated for 3 h at 37°C. After incubation, capsule extraction was performed as described below.
Extraction and analysis of surface proteins of E. coli CF604
Extraction of bacterial surface proteins was performed as described by Stirm et al. 11 Bacterial surface proteins were analysed by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), 12 using 12% (w/v) acrylamide and 0.8% (w/v) bisacrylamide for the separation gel. Samples were denatured in 1.5% (v/v) SDS-1.5% (v/v) 2-mercaptoethanol in 0.5 M Tris (pH 6.8) for 5 min at 100°C, before being loaded on to the gel. Electrophoresis was performed in a solution of 0.025 M Tris, 0.28 M glycine, and 0.1 (w/v) SDS (pH 8.6) and the gel was stained with Coomassie blue (2.5 g/L). The protein CF29K was identified by its molecular weight. 5 The molecular weight standards (Pharmacia Biotech, Saclay, France) were phos-phorylase b (94 kDa), albumin (67 kDa), ovalbumin (43 kDa), carbonic andydrase (30 kDa) and soybean trypsin inhibitor (20.1 kDa).
Analysis and quantification of the capsular polysaccharides of K. pneumoniae LM21
Extraction of capsular polysaccharides was performed as described by Linker & Jones.
13 Quantification of the capsular polysaccharides was performed by measuring the uronic acid content.
14 Briefly, the sample containing the capsular polysaccharides was layered on an ice-cold borate solution (1:40 (v/v) in concentrated H 2 SO 4 ). A 0.1% (w/v) carbazole solution was added to the mixture and the sample was heated for 30 min at 55°C to develop the colour reaction. Absorbance at 530 nm is indicative of a positive uronic acid test. Uronic acid concentration was determined from a standard curve of D-mannuronic acid ranging from 10 to 1000 mg/L. Total cellular protein was measured by a Bio-Rad protein assay (Bio-Rad, Ivry-SurSeine, France).
Results
Inhibitory effect of roxithromycin on the adhesion of K. pneumoniae
Addition of roxithromycin to the cell culture medium of Int-407 cell line markedly inhibited the adhesive capacity of K. pneumoniae 3051 ( Figure 1) ; this adhesive inhibitory effect ranged from 88.1% at MIC/2 to 67% at MIC/32, compared with controls.
Effect of intracellular concentration on the inhibitory effect of roxithromycin on adhesion
The intracellular concentration of roxithromycin induced by the addition of sodium bicarbonate reduced the inhibitory effect on adhesion (Figure 2a) . At a subinhibitory concentration of MIC/2, adherence was reduced by only 38% for K. pneumoniae CF504 and by 40% for K. pneumoniaeLM21, compared with values of almost 90% when roxithromycin was not concentrated intracellularly. 9 When intestinal cells were incubated with roxithromycin for 1 h before adding the bacteria, a weak inhibitory effect on adhesion was observed for both strains of K. pneumoniae (Figure 2b) . Figure 3 shows that adhesion was greatly reduced for K. pneumoniae LM21 and clearly reduced for K. pneumoniae CF504, with values of 80% and 50.5%, respectively of inhibition for a roxithromycin concentration of MIC/8.
Effect of roxithromycin on adhered bacteria
Effect of roxithromycin on the protein CF29K or on the capsule of K. pneumoniae LM21
After migration on SDS-PAGE (Figure 4 ), no apparent change was observed for the adhesin CF29K overexpressed in E. coli CF604 when bacteria were treated with subinhibitory concentrations of roxithromycin.
For K. pneumoniae LM21, the uronic acid content (and hence the quantity of capsular polysaccharides) was not significantly increased in the presence of subinhibitory concentrations of roxithromycin: without roxithromycin the capsular polysaccharide extract contained 1.94 Ϯ 0.08 ng of uronic acid/mg cellular protein; in the presence of
Discussion
Previous work has shown an inhibitory effect of roxithromycin on the diffuse adhesion of K. pneumoniae strain CF504 to Caco-2 cells. 8 We have also shown an inhibitory effect on adhesion for subinhibitory concentrations of roxithromycin in two strains of K. pneumoniae (CF504 and LM21), demonstrating diffuse and aggregative adhesion patterns, respectively. 9 In this case, the cell line used was Int-407; these cells are derived from human embryonic intestine.
The present study extended this work by examining the effect of subinhibitory concentrations of roxithromycin on K. pneumoniae strain 3051, which exhibits a diffuse adherence phenotype and has type 1 fimbriae thought to be responsible for this effect. It was shown that when roxithromycin was added to the culture medium of the Int-407 cells, adherence was markedly reduced and the effect was maintained at the lowest concentration tested (MIC/32).
Overall, these results suggest that the inhibitory effect of roxithromycin is related to a modification of the Int-407 cells or to a disturbance in the interaction between bacteria and eukaryotic cells since both cells and bacteria were in contact with roxithromycin.
Two further experiments suggest that extracellular roxithromycin has the major inhibitory effect on adhesion. Firstly, using bicarbonates which promote the intracellular penetration of roxithromycin, we observed that its inhibitory effect on adhesion was reduced. Secondly, when Int-407 cells were incubated with roxithromycin before adding bacteria, a weak inhibitory effect was observed. If we assume that during pre-incubation roxithromycin has penetrated the intestinal cells, intracellular roxithromycin did not appear to act on bacterial adhesion. Thus, when the intracellular concentration of roxithromycin was augmented there was a reduction in the inhibitory effect observed when roxithromycin was added to the cell culture medium.
The addition of roxithromycin to adherent bacteria also produced interesting results. After a period of 2 h, bacteria are bound to the monolayer of intestinal cells. Roxithromycin was able to release bacteria from the cells, suggesting that it could lead to the breakdown of the binding between bacteria and intestinal cells.
The inhibitory effect of roxithromycin is clear when the adhesion factor or the cellular receptor contain a polysaccharide fraction-for example, the cellular receptor for K. pneumoniae 3051 type 1 fimbriae 10 or the cellular receptor of K. pneumoniae CF504 CF29K adhesin. Di Martino et al. 15 showed that the eukaryotic receptor of adhesin CF29K contains a sialic acid (N-acetylneuraminic Analysis of surface proteins by SDS-PAGE revealed that the adhesin CF29K was not altered by exposure to roxithromycin. Likewise, the quantity of capsular polysaccharide synthesized by K. pneumoniae LM21 was not modified in the presence of subinhibitory concentrations of roxithromycin. Similar results have been reported for erythromycin and Pseudomonas aeruginosa. 16 In conclusion, we have shown an inhibitory effect of roxithromycin on the adhesion of three K. pneumoniae strains to intestinal cells; this effect is seen whatever adhesion factor is involved. Roxithromycin seems to modify the interaction between the adhesion factors and the eukaryotic receptor. Further work is now required to elucidate the target of roxithromycin and to investigate whether the components of the cladinose and desosamine residues of roxithromycin could inhibit adhesion.
